Chemotherapy-induced palmar plantar erythrodysesthesia syndrome (ppes) recall following different chemotherapy regimens in patients with leukemia

Medicine and Dentistry

• Chemotherapy 90%
• Patient 72%
• Troxacitabine 54%
• Cytarabine 36%
• Combination Therapy 27%
• Chemotherapy Regimens 27%
• Tezacitabine 27%
• Side Effect 18%
• Vincristine 18%
• Dexamethasone 18%
• Methotrexate 18%
• Asparaginase 18%
• Symptom 18%
• Desquamation 18%
• Topotecan 18%
• Fludarabine 18%
• Patient with Leukemia 18%
• Inpatient 18%
• Adverse Event 9%
• Toxicity 9%
• Drug Megadose 9%
• Steroid 9%
• Erythema 9%
• Walking Difficulty 9%
• Antiinfective Agent 9%
• Chemotherapeutic Agent 9%
• Pain 9%
• Salicylate Sodium 9%
• Hand Foot Syndrome 9%
• Dimethyl Sulfoxide 9%
• Recall 9%
• Antimitotic Agent 9%
• 7 Hydroxystaurosporine 9%
• Therapeutic Procedure 9%
• Skin 9%
• Cancer 9%
• Nucleoside Analogue 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Troxacitabine 54%
• Dolastatin 54%
• Cytarabine 36%
• Tezacitabine 27%
• Side Effect 18%
• Methotrexate 18%
• Dexamethasone 18%
• Vincristine 18%
• Asparaginase 18%
• Topotecan 18%
• Fludarabine 18%
• Desquamation 18%
• Symptom 18%
• Radiation 18%
• Toxicity 9%
• Adverse Event 9%
• Steroids 9%
• Nucleoside Analog 9%
• Dimethyl Sulfoxide 9%
• Pain 9%
• Hand Foot Syndrome 9%
• Salicylate Sodium 9%
• Antimitotic Agent 9%
• Erythema 9%
• 7 Hydroxystaurosporine 9%
• Walking Difficulty 9%
• Syndrome 9%
• Protein Kinase Inhibitor 9%

INIS

• patients 100%
• chemotherapy 72%
• therapy 27%
• symptoms 18%
• leukemia 18%
• doses 18%
• side effects 18%
• washout 18%
• methotrexate 18%
• dexamethasone 18%
• levels 9%
• radiations 9%
• proteins 9%
• skin 9%
• kinases 9%
• toxicity 9%
• refractories 9%
• erythema 9%
• malignancies 9%
• pain 9%
• irradiation 9%
• steroids 9%
• cytidine 9%
• nucleosides 9%
• dmso 9%